Cargando…
High-fidelity Glucagon-CreER mouse line generated by CRISPR-Cas9 assisted gene targeting
OBJECTIVE: α-cells are the second most prominent cell type in pancreatic islets and are responsible for producing glucagon to increase plasma glucose levels in times of fasting. α-cell dysfunction and inappropriate glucagon secretion occur in both type 1 and type 2 diabetes. Thus, there is growing i...
Autores principales: | Ackermann, Amanda M., Zhang, Jia, Heller, Aryel, Briker, Anna, Kaestner, Klaus H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323890/ https://www.ncbi.nlm.nih.gov/pubmed/28271030 http://dx.doi.org/10.1016/j.molmet.2017.01.003 |
Ejemplares similares
-
Comparison of the Opn-CreER and Ck19-CreER Drivers in Bile Ducts of Normal and Injured Mouse Livers
por: Lesaffer, Bram, et al.
Publicado: (2019) -
Tamoxifen-independent Cre-activity in SMMHC-CreER(T2) mice
por: Steffensen, L.B., et al.
Publicado: (2022) -
Genetic targeting of the endoderm with claudin-6(CreER)
por: Anderson, William J, et al.
Publicado: (2008) -
Tamoxifen-Independent Recombination in the RIP-CreER Mouse
por: Liu, Yanmei, et al.
Publicado: (2010) -
Genetic targeting of sprouting angiogenesis using Apln-CreER
por: Liu, Qiaozhen, et al.
Publicado: (2015)